Interleukin-6 in blood and bronchoalveolar lavage fluid of hospitalized children with community-acquired pneumonia

Yun Zhang; Wenyu Zheng; Haonan Ning; Jing Liu; Fuhai Li; Xiuli Ju

doi:10.3389/fped.2022.922143

Interleukin-6 in blood and bronchoalveolar lavage fluid of hospitalized children with community-acquired pneumonia

Front Pediatr. 2022 Sep 8:10:922143. doi: 10.3389/fped.2022.922143. eCollection 2022.

Authors

Yun Zhang¹, Wenyu Zheng¹, Haonan Ning¹, Jing Liu², Fuhai Li¹, Xiuli Ju¹

Affiliations

¹ Department of Pediatrics, Qilu Hospital of Shandong University, Jinan, China.
² Department of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China.

Abstract

Background: Host biomarkers and cytokines help in the prediction of disease severity in adults with community-acquired pneumonia (CAP). Accurate assessment of pathogens and disease severity is essential to clinical decision-making. There are few validated prognostic tools in blood and bronchoalveolar lavage for children with CAP to assist with proper decision and management.

Methods: We performed a retrospective study of 118 children under 18 years of age, hospitalized for CAP with bronchoalveolar lavage management within the first 2 days. The primary outcome was disease severity: mild (with no complications), moderate (with mild to moderate complications), and severe (with severe complications). Comparison and performance analysis of biomarkers and cytokines in the blood or bronchoalveolar lavage fluid (BALF) across different severity categories/different pathogens were performed.

Results: Analysis of 118 CAP cases revealed significant differences in the BALF levels of IL-6 (p = 0.000), CRP (p = 0.001), and ESR (p = 0.004) across different severity categories, while BALF IL-6 level was indicated as the best indicator to discriminate mild from moderate-to-severe cases with highest AUC (0.847, 95% CI: 0.748-0.946), fair sensitivity (0.839), and specificity (0.450), and severe from non-severe cases with highest AUC (0.847), sensitivity (0.917), and specificity (0.725). ALL biomarkers and cytokines exhibited no significant differences across different pathogen categories (p > 0.05), while BALF IL-6 (p = 0.000), blood ANC (p = 0.028), and ESR (p = 0.024) levels were obviously different in comparison to single Mycoplasma pneumoniae (MP)-, bacteria-, or virus-positive group vs. non-group. Blood CRP (r = 0.683, p = 0.000) and ESR (r = 0.512, p = 0.000) levels revealed significant correlation with the hospitalization course (HC). Among all the BALF cytokines, only BALF IL-6 showed a significant difference (p = 0.004, p < 0.01) across different severity categories, with good performance for predicting CAP severity in hospitalized children (AUC = 0.875, P = 0.004). Blood IL-6 and BALF IL-6 levels showed no significant correlation; in addition, BALF IL6 was better at predicting CAP severity in hospitalized children (AUC = 0.851, p = 0.011, p < 0.05) compared to blood IL-6.

Conclusion: BALF IL-6 and blood CRP levels, and ESR may have the ability for discriminating disease severity in hospitalized children with CAP, whereas WBC count and ANC have limited ability. No biomarkers or cytokines seemed to have the ability to predict the pathogen category, while BALF IL-6, blood ANC, and ESR may assist in the diagnosis of single MP, bacteria, and virus infections, respectively.

Keywords: C-reactive protein; bronchoalveolar lavage fluid; children; community-acquired pneumonia; disease severity; erythrocyte sedimentation rate; interleukin-6; pathogen detected.